Related Experiment Video
Updated: Jul 17, 2026

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
Published on: May 29, 2015
HAS1 expression in bladder cancer and its relation to urinary HA test
Roozbeh Golshani1, Stefan H Hautmann, Veronica Estrella
1Department of Cell Biology, University of Miami Miller School of Medicine, Miami, Florida 33101, USA.
Elevated hyaluronic acid synthase 1 (HAS1) expression in bladder tumors correlates with increased hyaluronic acid (HA) levels and a positive urine HA test, suggesting prognostic potential for bladder cancer.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Hyaluronic acid (HA) is elevated in bladder cancer and influences tumor progression.
- Urinary HA levels serve as an accurate diagnostic marker for bladder cancer.
- Hyaluronic acid is synthesized by HA-synthases (HAS1, HAS2, HAS3).
Purpose of the Study:
- To investigate the expression and role of HAS1 in bladder cancer.
- To determine the correlation between HAS1 expression, tissue HA levels, and urinary HA test results.
- To explore the prognostic significance of HAS1 expression in bladder cancer.
Main Methods:
- Real-time RT-PCR and northern blot analysis for HAS1 transcript levels.
- Immunohistochemical analysis for HAS1 and HA protein expression.
- Correlation analysis between HAS1/HA expression and clinical parameters.
Main Results:
- HAS1 transcript levels were significantly elevated (5- to 10-fold) in bladder cancer tissues compared to normal tissues.
- Increased HAS1 expression correlated with higher tissue HA levels and larger HA polymer size.
- HAS1 and HA expression demonstrated high sensitivity and specificity for bladder cancer and correlated with positive urine HA tests.
Conclusions:
- Elevated HAS1 expression in bladder tumors contributes to increased tissue HA and a positive urine HA test.
- HAS1 expression shows potential as a prognostic marker for bladder cancer recurrence and progression.
- HAS1 is a key enzyme in bladder cancer progression and a potential diagnostic/prognostic biomarker.
Related Concept Videos
Urinary Bladder
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
Nursing Assessment of the Genitourinary System I: Health History
Anatomy of the Genitourinary System II: Bladder and Urethra
Urine Studies I: Urinalysis
